{"id":31401,"date":"2020-04-23T06:34:16","date_gmt":"2020-04-23T06:34:16","guid":{"rendered":"https:\/\/www.arisglobal.com\/?p=31401"},"modified":"2020-04-23T06:34:16","modified_gmt":"2020-04-23T06:34:16","slug":"luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection","status":"publish","type":"post","link":"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/","title":{"rendered":"Luye Pharma Group Selects LifeSphere\u00ae Signal and Risk Management to Automate Drug Safety Signal Detection"},"content":{"rendered":"\nMIAMI, FL April 22, 2020<\/strong> – ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, today announced Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing, and sale of innovative medications, (02186.HK) has selected LifeSphere\u00ae<\/sup> Signal and Risk Management<\/a> as its next-generation signal detection tool.\n\nLuye Pharma has more than 30 products and a robust pipeline of over 40 drug candidates in China and over 10 drug candidates in other international markets. ArisGlobal\u2019s LifeSphere Signal and Risk Management will assist Luye Pharma to embrace advanced qualitative and quantitative in-depth signal detection and to streamline their risk management planning across their global locations.\n\nLuye Pharma Group is focused on developing innovative therapies targeting the central nervous system, oncology, and other areas with business covering over 80 countries and regions around the world. LifeSphere Signal and Risk Management will enable Luye Pharma to automate signal management across its drug development portfolio, thus improving operational efficiency. It will also provide Luye Pharma with an intuitive interface that utilizes advanced analytics to conduct ad-hoc analysis, drag and drop visualization, and reporting.\n
“Luye Pharma has over 30 products and a worldwide pipeline of more than 50 drug candidates. We need end-to-end product lifecycle capabilities and advanced analytics in order to go through large amounts of data. ArisGlobal\u2019s solution will help us optimize the process and improve the efficiency with its state-of-the-art technology.\u201d said Zhu Jie, Vice President of Pharmacovigilance Department, Luye Pharma Group.<\/blockquote>\n
\u201cWe\u2019re excited to have Luye Pharma leveraging LifeSphere Signal and Risk Management to implement effective signal detection strategies across their product portfolio,\u201d said Sankesh Abbhi<\/a>, President and CEO of ArisGlobal. \u201cThis landmark deal represents an extension of ArisGlobal’s growing footprint into the Chinese marketplace and further validation of the emphasis we\u2019ve put into developing industry-leading signal detection technology.\u201d<\/blockquote>\nLifeSphere Signal and Risk Management helps organizations to proactively identify and manage safety issues and easily assess their impact on a product\u2019s benefit-risk profile across its life cycle. It provides real-time safety profiling by analyzing multiple data sources simultaneously with advanced qualitative and quantitative methods for in-depth signal detection.\n\nTo learn more about LifeSphere Signal and Risk Management, visit our website: https:\/\/www.arisglobal.com\/products\/lifesphere-signal-and-risk-management-agbalance\/ <\/a>

About Luye Pharma Group<\/strong><\/h3>\nLuye Pharma Group is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications. The company has a robust pipeline of over 40 drug candidates in China and more than 10 drug candidates in other international markets. The company currently has a number of new drugs and new formulations in the central nervous system and oncology therapeutic areas under study in the U.S., Europe and Japan. Luye Pharma has set up 7 manufacturing sites with over 30 production lines in total, establishing GMP quality management and international standard control systems. The company offers more than 30 products covering the four largest and fastest growing therapeutic areas \u2014 oncology, cardiovascular, metabolism and central nervous system, with business conducted in over 80 countries and regions around the world, including the largest pharmaceutical markets – China, the U.S., Europe and Japan, as well as fast growing emerging markets.\n\nFor more information, visit Luye Pharma.<\/a>\n","protected":false},"excerpt":{"rendered":"

Luye Pharma Group, an international pharmaceutical has selected LifeSphere Signal and Risk Management as its next-generation signal detection tool.<\/p>\n","protected":false},"author":27,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65],"tags":[],"class_list":["post-31401","post","type-post","status-publish","format-standard","hentry","category-press-release"],"acf":[],"yoast_head":"\nLuye Pharma Group Selects LifeSphere Signal and Risk Management | ArisGlobal<\/title>\n<meta name=\"description\" content=\"Luye Pharma Group, an international pharmaceutical company has selected LifeSphere Signal and Risk Management to automate drug safety signal detection.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Luye Pharma Group Selects LifeSphere\u00ae Signal and Risk Management to Automate Drug Safety Signal Detection\" \/>\n<meta property=\"og:description\" content=\"Luye Pharma Group, an international pharmaceutical company has selected LifeSphere Signal and Risk Management to automate drug safety signal detection.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/\" \/>\n<meta property=\"og:site_name\" content=\"ArisGlobal\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LifeSphereAG\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-23T06:34:16+00:00\" \/>\n<meta name=\"author\" content=\"Mladen Prenc\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mladen Prenc\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/\"},\"author\":{\"name\":\"Mladen Prenc\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\"},\"headline\":\"Luye Pharma Group Selects LifeSphere\u00ae Signal and Risk Management to Automate Drug Safety Signal Detection\",\"datePublished\":\"2020-04-23T06:34:16+00:00\",\"dateModified\":\"2020-04-23T06:34:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/\"},\"wordCount\":547,\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/\",\"url\":\"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/\",\"name\":\"Luye Pharma Group Selects LifeSphere Signal and Risk Management | ArisGlobal\",\"isPartOf\":{\"@id\":\"https:\/\/www.arisglobal.com\/#website\"},\"datePublished\":\"2020-04-23T06:34:16+00:00\",\"dateModified\":\"2020-04-23T06:34:16+00:00\",\"description\":\"Luye Pharma Group, an international pharmaceutical company has selected LifeSphere Signal and Risk Management to automate drug safety signal detection.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.arisglobal.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Luye Pharma Group Selects LifeSphere\u00ae Signal and Risk Management to Automate Drug Safety Signal Detection\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arisglobal.com\/#website\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"name\":\"ArisGlobal\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.arisglobal.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arisglobal.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.arisglobal.com\/#organization\",\"name\":\"LifeSphere\",\"url\":\"https:\/\/www.arisglobal.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"LifeSphere\"},\"image\":{\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LifeSphereAG\/\",\"https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974\",\"name\":\"Mladen Prenc\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Luye Pharma Group Selects LifeSphere Signal and Risk Management | ArisGlobal","description":"Luye Pharma Group, an international pharmaceutical company has selected LifeSphere Signal and Risk Management to automate drug safety signal detection.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/","og_locale":"en_US","og_type":"article","og_title":"Luye Pharma Group Selects LifeSphere\u00ae Signal and Risk Management to Automate Drug Safety Signal Detection","og_description":"Luye Pharma Group, an international pharmaceutical company has selected LifeSphere Signal and Risk Management to automate drug safety signal detection.","og_url":"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/","og_site_name":"ArisGlobal","article_publisher":"https:\/\/www.facebook.com\/LifeSphereAG\/","article_published_time":"2020-04-23T06:34:16+00:00","author":"Mladen Prenc","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mladen Prenc","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/#article","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/"},"author":{"name":"Mladen Prenc","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974"},"headline":"Luye Pharma Group Selects LifeSphere\u00ae Signal and Risk Management to Automate Drug Safety Signal Detection","datePublished":"2020-04-23T06:34:16+00:00","dateModified":"2020-04-23T06:34:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/"},"wordCount":547,"publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/","url":"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/","name":"Luye Pharma Group Selects LifeSphere Signal and Risk Management | ArisGlobal","isPartOf":{"@id":"https:\/\/www.arisglobal.com\/#website"},"datePublished":"2020-04-23T06:34:16+00:00","dateModified":"2020-04-23T06:34:16+00:00","description":"Luye Pharma Group, an international pharmaceutical company has selected LifeSphere Signal and Risk Management to automate drug safety signal detection.","breadcrumb":{"@id":"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.arisglobal.com\/media\/press-release\/luye-pharma-group-selects-lifesphere-signal-risk-management-automate-drug-safety-signal-detection\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.arisglobal.com\/"},{"@type":"ListItem","position":2,"name":"Luye Pharma Group Selects LifeSphere\u00ae Signal and Risk Management to Automate Drug Safety Signal Detection"}]},{"@type":"WebSite","@id":"https:\/\/www.arisglobal.com\/#website","url":"https:\/\/www.arisglobal.com\/","name":"ArisGlobal","description":"","publisher":{"@id":"https:\/\/www.arisglobal.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arisglobal.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.arisglobal.com\/#organization","name":"LifeSphere","url":"https:\/\/www.arisglobal.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"LifeSphere"},"image":{"@id":"https:\/\/www.arisglobal.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LifeSphereAG\/","https:\/\/www.linkedin.com\/products\/aris-global-lifesphere\/"]},{"@type":"Person","@id":"https:\/\/www.arisglobal.com\/#\/schema\/person\/bb2c7aafe44a090bcd667448651eb974","name":"Mladen Prenc"}]}},"_links":{"self":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/31401"}],"collection":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/comments?post=31401"}],"version-history":[{"count":0,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/posts\/31401\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/media?parent=31401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/categories?post=31401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.arisglobal.com\/wp-json\/wp\/v2\/tags?post=31401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}